• 1
    Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can. J. Psychiatry 2008; 53: 555566.
  • 2
    Schutter DJLG. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol. Med. 2009; 39: 6575.
  • 3
    Stafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 2001; 15: RC157.
  • 4
    Stafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003; 126: 26092615.
  • 5
    Pogarell O, Koch W, Popperl G et al. Striatal magnetic stimulation in major depression: preliminary results of a dynamic [123I]IBZM SPECT study. J. Psychiatr. Res. 2006; 40: 307314.
  • 6
    Kuroda Y, Motohashi N, Ito H et al. Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression. J. Affect. Disord. 2006; 95: 3542.
  • 7
    Ito H, Ota M, Ikoma Y et al. Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[β-11C]DOPA. Nucl. Med. Commun. 2006; 27: 723731.
  • 8
    Wassermann EM. Risk and safety repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation. Electroencephalogr. Clin. Neurophysiol. 1998; 108: 116.
  • 9
    Wassermann EM, Wang B, Zeffiro TA et al. Locating the motor cortex on the MRI with transcranial magnetic stimulation and PET. Neuroimage 1996; 3: 19.
  • 10
    Hamilton N. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 5662.
  • 11
    Bjurling P, Watanabe Y, Oka S, Nagasawa T, Yamada H, Langstorm B. Multi-enzymatic syntheses of beta-11C-labeled L-tyrosine and L-DOPA. Acta Chem. Scand. 1990; 44: 183188.
  • 12
    Sasaki M, Ikemoto M, Mutoh M et al. Automatic synthesis of L-[β-11C]amino acids using an immobilized enzyme column. Appl. Radiat. Isot. 2000; 52: 199204.
  • 13
    Gefvert O, Lindstorm LH, Waters N, Waters S, Carlsson A, Tedroff J. Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scand. J. Psychol. 2003; 44: 289292.
  • 14
    Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data generalization. J. Cereb. Blood Flow Metab. 1985; 5: 584590.
  • 15
    Tsukada H, Miyasato K, Harada N, Nishiyama S, Fukumoto D, Kakiuchi T. Nicotine modulates dopamine synthesis rate as determined by L-[β-11C]DOPA: PET studies compared with [11C]raclopride binding in the conscious monkey brain. Synapse 2005; 57: 120122.